PCYC

PCYC: Completes Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 - 11/25 - 09:18 AM ET

Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 - 11/25 - 08:00 AM ET

BRIEF-Pharmacyclics reports Q1 results - 10/30 - 07:38 AM ET

Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results - 10/30 - 07:30 AM ET

BRIEF-Pharmacyclics names Robert Duggan interim CFO - 10/16 - 03:01 PM ET

PHARMACYCLICS INC SAYS NAMED ROBERT DUGGAN INTERIM CFO - SEC FILING - 10/16 - 02:58 PM ET

Pharmacyclics Responds to Nasdaq Letter - 09/30 - 05:06 PM ET

Pharmacyclics, Inc. Announces Board and Management Transitions - 09/11 - 05:22 PM ET

Pharmacyclics Sets New High For The Year - 09/10 - 08:18 AM ET

Pharmacyclics Closes At Yearly High - 09/05 - 04:20 PM ET

Pharmacyclics Closes At Multi-Month High - 09/04 - 04:15 PM ET

PCYC: Q4 Earnings Call @ 16:30 ET Today [delayed] - 08/14 - 01:53 PM ET

Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results - 08/14 - 07:30 AM ET

Pharmacyclics Inc. (PCYC) Corporate Event Announcement Notice - 06/13 - 08:59 PM ET

Pharmacyclics Inc. (PCYC) Corporate Event Announcement Notice - 06/12 - 09:01 PM ET

Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma - 06/09 - 07:30 AM ET

Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkin's Lymphoma - 06/05 - 07:30 AM ET

PCYC: RWD Acquisition Announces Expiration of Tender Offer - 06/02 - 09:33 AM ET

RWD Acquisition I LLC Announces Expiration of Tender Offer - 06/02 - 08:19 AM ET

PCYC: Receives Notice of Compliance from Nasdaq - 05/30 - 08:25 AM ET

Page 1 of 4     1  2   3   4      Previous  |  Next

<< Back to Stock Index